Treatment of advanced (Stages III and IV) non—small-cell lung cancer
- 30 April 1998
- journal article
- review article
- Published by Elsevier in Current Problems in Cancer
- Vol. 22 (2) , 87-132
- https://doi.org/10.1016/s0147-0272(98)90010-1
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerCancer, 1995
- A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancerEuropean Journal Of Cancer, 1994
- Phase I–II study of vinorelbine (Navelbine®) plus cisplatin in advanced non-small cell lung cancerEuropean Journal Of Cancer, 1992
- The Current and Future Place of Vinorelbine in Cancer TherapyDrugs, 1992
- Non-small cell lung cancer Part II: TreatmentCurrent Problems in Cancer, 1991
- Inoperable non-small cell lung cancer: Radiation with or without chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1988
- Effects of Postoperative Mediastinal Radiation on Completely Resected Stage II and Stage III Epidermoid Cancer of the LungNew England Journal of Medicine, 1986
- Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)Cancer, 1982
- Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinomaCancer, 1982